Search

everythinglearnresearchcommunity

for

Search:↓

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

5α-reductase inhibitors can reduce prostate cancer risk but may increase high-grade tumors, needing more research.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

Long-term use of a certain medication can worsen erectile function in aged rats by damaging penile muscle cells.

Higher doses of 5α-reductase inhibitors reduce mortality risk, while lower doses increase suicide risk.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Baricitinib significantly improves hair regrowth in severe alopecia areata.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Baricitinib helped regrow hair in patients with severe alopecia areata after other treatments failed.

New drug dutasteride effectively treats hair loss, but use cautiously due to potential sexual side effects.

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Apremilast did not work for treating severe alopecia areata.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Baricitinib stops hair loss and promotes regrowth in alopecia areata.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

5-alpha reductase inhibitors help with benign prostatic hyperplasia but don't cure it, and more research is needed.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.